Literature DB >> 4048759

A new assay for IgG rheumatoid factor activity and its use to analyse rheumatoid factor reactivity with human IgG isotypes.

C J Elson, S D Carter, D G Scott, P A Bacon, J Lowe.   

Abstract

A new assay for IgGRF activity is described which employs human IgGFc as the antigen and a radiolabelled monoclonal antibody directed against human IgG (CHI domain) as the developing antibody. Using this assay IgGRF activity against human IgG isotypes was measured and most sera from RA patients were shown to react predominantly with IgG1 and IgG2 but few reacted with IgG3 and IgG4. The same sera were tested for IgMRF to the IgG isotypes. IgG2 was the best antigen, IgG1 and IgG4 were less so and reactivity with IgG3 was the lowest. IgGRF without associated IgMRF was obtained, its specificity compared to that of IgMRF, and found to be broadly similar. With the new assay high levels of serum IgGRF were found in those RA patients with extraarticular disease but not in RA patients with synovitis alone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4048759     DOI: 10.1007/BF00541519

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

1.  The use of baboon IgG-sensitized sheep erythrocytes as an alternative indicator system in the study of the interaction of rheumatoid factor with human IgG.

Authors:  G A Stewart; I M Hunneyball; D R Stanworth
Journal:  Immunochemistry       Date:  1975-08

2.  Specificity of rheumatoid factors cross-reacting with human and rabbit IgG.

Authors:  P I Gaarder; T E Michaelsen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-10

3.  Hidden rheumatoid factors with specificity for native gamma globulins.

Authors:  J C Allen; H G Kunkel
Journal:  Arthritis Rheum       Date:  1966-12

4.  Interactions between rheumatoid factor and native gamma-G-globulins studied in the ultracentrifuge.

Authors:  D E Normansell; D R Stanworth
Journal:  Immunology       Date:  1968-10       Impact factor: 7.397

5.  Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG.

Authors:  D A Carson; S Lawrance; M A Catalano; J H Vaughan; G Abraham
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

6.  Antigammaglobulin (rheumatoid factor) activity of human IgG subclasses.

Authors:  F Shakib; D R Stanworth
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

7.  IgG antiglobulins in rheumatoid arthritis and other arthritides: relationship with clinical features and other parameters.

Authors:  C Allen; C J Elson; D G Scott; P A Bacon; R C Bucknall
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

8.  IgG rheumatoid factor. Relationship to seropositive rheumatoid arthritis and absence in seronegative disorders.

Authors:  R M Pope; S J McDuffy
Journal:  Arthritis Rheum       Date:  1979-09

Review 9.  Rheumatoid factor: its nature, specificity, and production in rheumatoid arthritis.

Authors:  P M Johnson; W P Faulk
Journal:  Clin Immunol Immunopathol       Date:  1976-11

10.  The isolation of immune complexes containing IgM rheumatoid factor and recovery of IgG rheumatoid factor from the complexes.

Authors:  V E Jones; P J Cowley; C Allen; C J Elson
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

View more
  4 in total

1.  Clinical value of ELISA assays for IgM and IgG rheumatoid factors.

Authors:  R Stone; J S Coppock; P T Dawes; P A Bacon; D L Scott
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

Review 2.  Is measurement of rheumatoid factor isotypes clinically useful?

Authors:  T Jónsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

Review 3.  Rheumatoid factors in immune complexes of patients with rheumatoid arthritis.

Authors:  M Mannik; F A Nardella; E H Sasso
Journal:  Springer Semin Immunopathol       Date:  1988

4.  Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.

Authors:  A E Bedwell; C J Elson; S D Carter; P A Dieppe; C W Hutton; R Czudek
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.